BrightPath Biotherapeutics Co., Ltd. logo

BrightPath Biotherapeutics Co., Ltd.

TSE:4594.T

Overview | Financials
Company Name BrightPath Biotherapeutics Co., Ltd.
Symbol 4594.T
Currency JPY
Price 53
Market Cap 4,387,938,847
Dividend Yield 0%
52-week-range 43 - 148
Industry Biotechnology
Sector Healthcare
CEO Mr. Kenichi Nagai
Website https://www.brightpathbio.com

An error occurred while fetching data.

About BrightPath Biotherapeutics Co., Ltd.

BrightPath Biotherapeutics Co., Ltd. develops cancer immunotherapy drugs. The company is developing GRN-1201 that is in Phase II clinical study for the treatment of non-small cell lung cancer, as well as in Phase I clinical study to treat melanoma. It also develops BP1101, a neoantigen vaccine; BP1209, a platform of

Related Stocks

TOWA Hi SYSTEM CO.,LTD. logo

TOWA Hi SYSTEM CO.,LTD.

4172.T

1,818 JPY

Welby Inc. logo

Welby Inc.

4438.T

408 JPY

Yamashita Health Care Holdings,Inc. logo

Yamashita Health Care Holdings,Inc.

9265.T

2,615 JPY

UCHIYAMA HOLDINGS Co.,Ltd. logo

UCHIYAMA HOLDINGS Co.,Ltd.

6059.T

331 JPY

teno. Holdings Company Limited logo

teno. Holdings Company Limited

7037.T

440 JPY

Sincere Co., LTD. logo

Sincere Co., LTD.

7782.T

416 JPY

Artra Group Corporation logo

Artra Group Corporation

6029.T

134 JPY

baby calendar Inc. logo

baby calendar Inc.

7363.T

1,426 JPY

Pharmarise Holdings Corporation logo

Pharmarise Holdings Corporation

2796.T

609 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD